InVivo Therapeutics Corp BPA estimée Q/Q
Quel est le BPA estimée Q/Q de InVivo Therapeutics Corp?
Le BPA estimée Q/Q de InVivo Therapeutics Holdings Corp est -35.71%
Quelle est la définition de BPA estimée Q/Q?
Le taux de croissance prospectif du BPA trimestriel, d'une année à l'autre , correspond à l'augmentation estimée du BPA d'une entreprise pour le prochain trimestre par rapport à la performance d'un trimestre précédent.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
BPA estimée Q/Q des entreprises dans Health Care secteur sur NASDAQ par rapport à InVivo Therapeutics Corp
Que fait InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Entreprises avec bpa estimée q/q similaire à InVivo Therapeutics Corp
- Chiasma Inc a BPA estimée Q/Q de -36.00%
- Tide Water Oil Co. (India) a BPA estimée Q/Q de -35.86%
- Fresenius Medical Care AG a BPA estimée Q/Q de -35.85%
- Exelon a BPA estimée Q/Q de -35.78%
- Exelon a BPA estimée Q/Q de -35.78%
- Mallinckrodt Plc a BPA estimée Q/Q de -35.75%
- InVivo Therapeutics Corp a BPA estimée Q/Q de -35.71%
- Calithera Biosciences Inc a BPA estimée Q/Q de -35.67%
- Allstate Corp a BPA estimée Q/Q de -35.64%
- DarioHealth Corp a BPA estimée Q/Q de -35.59%
- Perdoceo Education a BPA estimée Q/Q de -35.56%
- Aeglea BioTherapeutics Inc a BPA estimée Q/Q de -35.48%
- BioNTech SE a BPA estimée Q/Q de -35.42%